跳至主要内容
临床试验/NCT04299477
NCT04299477已完成不适用

EVALUATION OF THE EFFETCS OF NON-SURGICAL PERIODONTAL TREATMENT ON SALIVARY BIOMARKERS OF PATIENTS UNDERGOING BISPHOSPHONATE THERAPY

Gazi University2 个研究点 分布在 2 个国家目标入组 75 人开始时间: 2018年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
2
主要终点
salivary levels of IL-17 at 1-month

研究概览

简要总结

Inflammatory mediators in periodontitis may lead to elevated systemic cytokine levels, resulting in increased bone resorption including the jaws. Osteoporosis may have an influence on the periodontal condition of post-menopausal women and the risk for periodontal disease may increase due to osteoporosis. The hypothesis of the study was that non-surgical periodontal treatment and medical treatment of osteoporosis by bisphosphonates may improve the clinical outcomes and decrease salivary levels of IL-1β, IL-17, ALP and 8-OHdG. Therefore, the aim of this study was to evaluate the mechanism of bi-directional relationship between osteoporosis and periodontal diseases and to investigate the outcomes of non-surgical periodontal treatment with regard to salivary levels of IL-1β, IL-17, 8-OHdG and ALP in patients with periodontitis and osteoporosis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The participants were postmenopausal patients defined as absence of menstruation for at least 12 months.
  • Patients with periodontitis;
  • Patients who had no systemic diseases and were periodontally healthy (no attachment loss),
  • Patients who were treated with oral bisphosphonate at least one year (70 mg tablet once weekly)

排除标准

  • if they had received any periodontal treatment in the preceding three months,
  • if they were pregnant or in the period of lactation,
  • if they had systemic diseases that may interfere with normal healing mechanism,
  • if they had taken antibiotics, anticonvulsants, immunosuppressants, calcium channel blockers in the preceding six months.

结局指标

主要结局

salivary levels of IL-17 at 1-month

时间窗: 1-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of IL-17 in g/ml

salivary levels of 8-hydroxydeoxyguanosine at 3-month

时间窗: 3-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of 8-hydroxydeoxyguanosine in g/ml

salivary levels of IL-17 baseline

时间窗: baseline

evaluation of the salivary levels of IL-17 in g/ml

salivary levels of IL-17 at 3-month

时间窗: 3-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of IL-17 in g/ml

salivary levels of alkaline phosphatase at 1-month

时间窗: 1-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of alkaline phosphatase in g/ml

salivary levels of 8-hydroxydeoxyguanosine at 1-month

时间窗: 1-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of 8-hydroxydeoxyguanosine in g/ml

salivary levels of IL-1β at baseline

时间窗: baseline

evaluation of the salivary levels of IL-1β in g/ml

salivary levels of IL-1β at 1-month

时间窗: 1-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of IL-1β in g/ml

salivary levels of IL-1β at 3-month

时间窗: 3-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of IL-1β in g/ml

salivary levels of alkaline phosphatase at 3-month

时间窗: 3-month follow-up after non-surgical periodontal therapy

evaluation of the salivary levels of alkaline phosphatase in g/ml

salivary levels of alkaline phosphatase at baseline

时间窗: baseline

evaluation of the salivary levels of alkaline phosphatase in g/ml

salivary levels of 8-hydroxydeoxyguanosine at baseline

时间窗: baseline

evaluation of the salivary levels of 8-hydroxydeoxyguanosine in g/ml

次要结局

  • gingival index(baseline, 1- and 3-month follow- up.)
  • clinical attachment level(baseline, 1- and 3-month follow- up.)
  • Plaque index(baseline, 1- and 3-month follow- up.)
  • probing depth(baseline, 1- and 3-month follow- up.)
  • bleeding on probing(baseline, 1- and 3-month follow- up.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Basak Karasu

Principal Investigator

Gazi University

研究点 (2)

Loading locations...

相似试验